Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Callaghan

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Allergy and Clinical Immunology|June 1, 1983
Correlation of in vivo and in vitro expression of cell-mediated immunity to mumps skin test antigenB H Petersen, J T Callaghan, L A Steimel, et al.
Urology|December 1, 1990
Role of serum prolactin determination in evaluation of impotent patientR S Foster, J J Mulcahy, J T Callaghan, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Absorption studies of the H2-blocker nizatidineM P Knadler, R F Bergstrom, J T Callaghan, et al.
Clinical Pharmacology and Therapeutics|February 1, 1985
Intravenous nizatidine kinetics and acid suppressionJ T Callaghan, R F Bergstrom, B D Obermeyer, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
Relationship between steady-state plasma nizatidine concentrations and inhibition of basal and stimulated gastric acid secretionD W Schneck, J T Callaghan, R F Bergstrom, et al.
JAMA|September 22, 1989
In-flight medical emergencies. One year of experience with the enhanced medical kitJ J Cottrell, J T Callaghan, G M Kohn, et al.
Clinical Pharmacology and Therapeutics|June 1, 1988
Nizatidine disposition in subjects with normal and impaired renal functionG R Aronoff, R F Bergstrom, R J Bopp, et al.
Clinical Immunology and Immunopathology|January 1, 1983
Delayed hypersensitivity to mumps antigen in humansJ T Callaghan, B H Petersen, W C Smith, et al.
Clinical Pharmacology and Therapeutics|June 1, 1990
Secretion of nizatidine into human breast milk after single and multiple dosesB D Obermeyer, R F Bergstrom, J T Callaghan, et al.
Pharmacotherapy|December 17, 1998
Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy menW L Macias, R F Bergstrom, B J Cerimele, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology|June 1, 1983
Correlation of in vivo and in vitro expression of cell-mediated immunity to mumps skin test antigenB H Petersen, J T Callaghan, L A Steimel, et al.
Urology|December 1, 1990
Role of serum prolactin determination in evaluation of impotent patientR S Foster, J J Mulcahy, J T Callaghan, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Absorption studies of the H2-blocker nizatidineM P Knadler, R F Bergstrom, J T Callaghan, et al.
Clinical Pharmacology and Therapeutics|February 1, 1985
Intravenous nizatidine kinetics and acid suppressionJ T Callaghan, R F Bergstrom, B D Obermeyer, et al.
Clinical Pharmacology and Therapeutics|April 1, 1990
Relationship between steady-state plasma nizatidine concentrations and inhibition of basal and stimulated gastric acid secretionD W Schneck, J T Callaghan, R F Bergstrom, et al.
JAMA|September 22, 1989
In-flight medical emergencies. One year of experience with the enhanced medical kitJ J Cottrell, J T Callaghan, G M Kohn, et al.
Clinical Pharmacology and Therapeutics|June 1, 1988
Nizatidine disposition in subjects with normal and impaired renal functionG R Aronoff, R F Bergstrom, R J Bopp, et al.
Clinical Immunology and Immunopathology|January 1, 1983
Delayed hypersensitivity to mumps antigen in humansJ T Callaghan, B H Petersen, W C Smith, et al.
Clinical Pharmacology and Therapeutics|June 1, 1990
Secretion of nizatidine into human breast milk after single and multiple dosesB D Obermeyer, R F Bergstrom, J T Callaghan, et al.
Pharmacotherapy|December 17, 1998
Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy menW L Macias, R F Bergstrom, B J Cerimele, et al.
Pageof 4